Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

100-MSPS ADC for Imaging Applications

January 31, 2013 10:28 am | Texas Instruments Inc. | Product Releases | Comments

Texas Instruments Incorporated (TI) (NASDAQ: TXN) today introduced an octal, 12-bit, 100-MSPS analog-to-digital converter (ADC) that provides the lowest power consumption in its class.

135 W Desktop Medical Power Supplies

January 31, 2013 10:24 am | Protek Power | Product Releases | Comments

The PMP135 Series of AC/DC power supplies from Protek Power offer 135 watts of performance packed design and are compliant to UL60601-1 and EN60101-1 3rd Edition medical safety standards.

Novel Absorbable Scaffold for Breakthrough Surgical Applications

January 31, 2013 10:21 am | Product Releases | Comments

Biomedical Structures, LLC (BMS), a designer, developer and manufacturer of biomedical textiles for medical devices and other advanced clinical applications, announced its BIOFELT® absorbable scaffold for implant devices...

TOPICS:
Advertisement

Commitment to Research Earns Carestream 43 U.S. Patents in 2012

January 31, 2013 10:15 am | by The Associated Press | News | Comments

ROCHESTER, N.Y.--(BUSINESS WIRE)--Jan 31, 2013--Carestream was awarded 43 patents from the U.S. Patent and Trademark Office in 2012 for innovations in radiology imaging, healthcare IT, dental imaging and other areas, capping another strong year for technology development across its businesses. ...

TruTouch Technologies Tops Up $4.3M B-1 Round of Financing; iTulip Community & Launchpad Venture Group as Leads

January 31, 2013 10:00 am | by The Associated Press | News | Comments

FRAMINGHAM, Mass. & RIVERSIDE, Calif.--(BUSINESS WIRE)--Jan 31, 2013--TruTouch Technologies, a pioneer in non-invasive biometric alcohol detection systems, today announced that it has topped up its B-1 Financing to $4.3M, which will enable the company to build sales revenues towards...

BioTime’s Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTM

January 31, 2013 9:05 am | by The Associated Press | News | Comments

ALAMEDA, Calif.--(BUSINESS WIRE)--Jan 31, 2013--BioTime, Inc. (NYSE MKT: BTX) and BioTime’s subsidiary OncoCyte Corporation provided an update on the progress of development of PanC-DxTM, a novel blood-based diagnostic test utilizing molecular markers discovered at BioTime and OncoCyte designed to...

TOPICS:

World's First Personal Breast Health Scanner Helps Detect Potential Masses During In-Home Breast Self-Exams

January 31, 2013 9:00 am | by The Associated Press | News | Comments

CARLSBAD, Calif.--(BUSINESS WIRE)--Jan 31, 2013--Eclipse Breast Health Technologies Inc., a health products design and development company, today announced the Eclipse breast health scanner, the world’s first personal handheld device that creates digital images women can monitor to help identify...

Micro Imaging Technology's Eye on the Future

January 31, 2013 8:00 am | by The Associated Press | News | Comments

Micro Imaging Technology, Inc. (OTCQB: MMTC) MIT has developed and patented the MIT 1000, a Microbial Identification System that revolutionizes the pathogenic bacteria diagnostic process and can annually save thousands of lives and tens of millions of dollars in health care costs. This...

Advertisement

Intersect ENT Initiates U.S. Clinical Study of a Novel In-Office Treatment for Chronic Sinusitis Patients

January 31, 2013 8:00 am | by The Associated Press | News | Comments

MENLO PARK, Calif.--(BUSINESS WIRE)--Jan 31, 2013--Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat clinicians and their patients, today announced the start of RESOLVE, a prospective, randomized, blinded, multi-center clinical trial to study the use of the...

IBM PureFlex Enables Leading Russian Hospital to Improve Patient Care While Powering Advanced Medical Research

January 30, 2013 10:36 pm | by IBM | News | Comments

Russian Federal Scientific-Clinical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, has signed a contract with IBM to implement one of IBM's new PureFlex integrated systems. The solution, which is the first of its kind to be deployed in Russia, will help the research institute to improve patient care and draw insight from its clinical data. The revolutionary new PureFlex technology means that the hospital will be able to deploy the new system rapidly and crucial medical applications will be up and running much faster than with competitive systems. E-mail this page Save to del.icio.us Digg this

NeuroSigma Announces Publication of Randomized Controlled Trial of eTNS for Treatment of Drug Resistant Epilepsy in the Leading Journal, Neurology@

January 30, 2013 5:46 pm | by The Associated Press | News | Comments

NeuroSigma, Inc., a California-based medical device company, today announced the publication of a positive Phase II clinical study for the use of external Trigeminal Nerve Stimulation (eTNST) for the treatment of drug-resistant epilepsy. The study, led by Christopher M. DeGiorgio, M.D.,...

BlackRock boosts medical device stakes

January 30, 2013 5:36 pm | by Mass Device | News | Comments

Hedge fund goliath BlackRock Inc. boosts its stake in a bevy of medical device companies. BlackRock Inc., 1 of the world's largest hedge funds, boosted its stake in a clutch of medical device companies, with 1 exception. News Well, Funding Roundup, Wall Street Beatread more

Mixed review for Biotronik's absorbable stent

January 30, 2013 4:31 pm | by Mass Device | News | Comments

Biotronik touted positive early findings from a 1st-in-man trial of its absorbable metal stent, but researchers say the device need isn't as efficient as it could be. German medical device maker Biotronik touted early findings from a 1st-in-man study of its Dreams absorbable drug-eluting stent, with researchers reporting a mixed bag of findings for the device. The Dreams stent proved safe at 1 year following the procedure, but wasn't up to par with some rival devices, researchers noted. News Well, Clinical Trials, Bioabsorbable Stentsread more

SurModics Reports First Quarter Fiscal 2013 Results

January 30, 2013 4:01 pm | by The Associated Press | News | Comments

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Jan 30, 2013--SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industries, today announced results for its fiscal 2013 first quarter. Commenting on the Company’s results,...

TOPICS:

Women’s Health News: Alleged Complications of Mirena IUD and Mirena Lawsuits Summarized by Injury Attorney Wendy Fleishman

January 30, 2013 4:00 pm | by The Associated Press | News | Comments

NEW YORK--(BUSINESS WIRE)--Jan 30, 2013--Wendy R. Fleishman, a personal injury attorney with the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, has released a video on YouTube discussing the alleged serious side effects of Mirena, an intrauterine device (IUD) used by...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading